bibliographicCitation |
Barrios CH, Liu M, Lee SC, Vanlemmens L, Ferrero J, Tabei T, Pivot X, Iwata H, Aogi K, Lugo-Quintana R, Harbeck N, Brickman MJ, Zhang K, Kern KA, Martin M. Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer. Breast Cancer Research and Treatment. 2010 Mar 26;121(1):121–31. doi: 10.1007/s10549-010-0788-0. |